Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortProgestin used for breast and endometrial cancer and for appetite loss.Contraceptive injection every 13 weeks.
Body systemSexual & ReproductiveSexual & Reproductive
Drug classProgestogens (non-contraceptive uses)Progestogens
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesAdvanced endometrial and breast cancer, Appetite loss and weight loss in cancer or AIDSContraception, Heavy periods, Endometriosis
How it worksHormone treatment that slows some hormone-driven cancers and boosts appetite.Stops ovulation for three months at a time.
Starts workingDepends on the cancer and regimen—
Half-lifeAbout 30–60 hours—
Typical adult doseDosed by your cancer team according to the treatment protocol.150 mg IM (or 104 mg SC) every 13 weeks.
FormsTablet, Oral suspensionIntramuscular injection, Subcutaneous self-injection, Tablet (other uses)
Common side effectsWeight gain, Swollen ankles, Hot flushes, Nausea, Breakthrough bleedingIrregular bleeding then often no periods, Weight gain, Headache, Mood changes
Serious side effectsBlood clots, Adrenal suppression, High blood sugarBone density loss (recovers after stopping), Meningioma (rare, with long use)
Don't take ifPregnancy; Past blood clots (caution)—
AlcoholUsually no problem in moderation. No specific interaction.—
PregnancyUsually avoidedAvoid.Usually avoidedNot for use in pregnancy.
BreastfeedingUsually avoidedAvoid.—
In use since—1992
Brand namesUnited States: Megace, Megace ESUnited Kingdom: MegaceIndia: Megace, Megestrol (generic)United States: Depo-Provera, Depo-SubQ Provera 104United Kingdom: Depo-Provera, Sayana PressIndia: Depo-Provera, Antara
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeL02AB01G03AC06

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker